| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_155ecba795cfc880c48ed21eb0378963
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_411075be438c72b29efe1ff81a543756
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b805f4e227fdf04bee025eedd33122a9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2503-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate |
2011-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82a970b6c59af7c407b204adafdde196 |
| publicationDate |
2011-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011090068-A1 |
| titleOfInvention |
Culture method, evaluation method and storage method for cancer-tissue-derived cell mass or aggregated cancer cell mass |
| abstract |
Disclosed is a method for culturing a novel cancer-tissue-derived cell mass or a novel aggregated cancer cell mass which can reflect the behavior of cancer cells accurately in vivo .nFirst, a cancer-tissue-derived cell mass or an aggregated cancer cell mass is prepared from an individual. The novel cancer-tissue-derived cell mass or the novel aggregated cancer mass is cultured, and the evaluation of properties can be carried out using the cultured product. The evaluation of properties include the evaluation of genes, the evaluation of culture conditions and the like. The cancer-tissue-derived cell mass or the aggregated cancer cell mass can be stored. It becomes possible to establish the optimum therapy method for an individual from which the cancer-tissue-derived cell mass or the aggregated cancer cell mass is derived, efficiently by linking the clinical information or the genetic information on the individual to the stored cancer-tissue-derived cell mass or the stored aggregated cancer cell mass. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016059290-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11591573-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11753626-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018531021-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7112957-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7202613-B2 |
| priorityDate |
2010-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |